Eliem Therapeutics Inc (ELYM)
8.66
-0.22
(-2.48%)
USD |
NASDAQ |
Jun 10, 16:00
8.73
+0.07
(+0.81%)
After-Hours: 20:00
Eliem Therapeutics Enterprise Value: 146.90M for June 10, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 10, 2024 | 146.90M |
| June 07, 2024 | 153.30M |
| June 06, 2024 | 141.66M |
| June 05, 2024 | 148.64M |
| June 04, 2024 | 134.39M |
| June 03, 2024 | 137.59M |
| May 31, 2024 | 119.26M |
| May 30, 2024 | 117.81M |
| May 29, 2024 | 118.10M |
| May 28, 2024 | 117.81M |
| May 24, 2024 | 110.53M |
| May 23, 2024 | 111.41M |
| May 22, 2024 | 123.92M |
| May 21, 2024 | 123.04M |
| May 20, 2024 | 133.52M |
| May 17, 2024 | 134.97M |
| May 16, 2024 | 132.94M |
| May 15, 2024 | 127.41M |
| May 14, 2024 | 133.23M |
| May 13, 2024 | 139.63M |
| May 10, 2024 | 141.08M |
| May 09, 2024 | 155.34M |
| May 08, 2024 | 153.35M |
| May 07, 2024 | 177.75M |
| May 06, 2024 | 134.78M |
| Date | Value |
|---|---|
| May 03, 2024 | 176.50M |
| May 02, 2024 | 127.57M |
| May 01, 2024 | 104.84M |
| April 30, 2024 | 91.53M |
| April 29, 2024 | 34.14M |
| April 26, 2024 | 5.310M |
| April 25, 2024 | -11.05M |
| April 24, 2024 | -3.562M |
| April 23, 2024 | -1.067M |
| April 22, 2024 | 2.260M |
| April 19, 2024 | 1.706M |
| April 18, 2024 | 10.85M |
| April 17, 2024 | 17.79M |
| April 16, 2024 | 21.39M |
| April 15, 2024 | 26.66M |
| April 12, 2024 | 14.46M |
| April 11, 2024 | 21.94M |
| April 10, 2024 | -31.01M |
| April 09, 2024 | -30.45M |
| April 08, 2024 | -30.45M |
| April 05, 2024 | -32.95M |
| April 04, 2024 | -27.68M |
| April 03, 2024 | -28.24M |
| April 02, 2024 | -27.13M |
| April 01, 2024 | -27.40M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-62.46M
Minimum
Feb 16 2023
806.24M
Maximum
Sep 07 2021
47.15M
Average
-28.83M
Median
May 05 2022
Enterprise Value Benchmarks
| Alpine Immune Sciences Inc (DELISTED) | 4.151B |
| Candel Therapeutics Inc | 204.01M |
| Cyclacel Pharmaceuticals Inc | -0.047M |
| Lipocine Inc | 17.56M |
| GlycoMimetics Inc | -14.59M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.697M |
| Total Expenses (Quarterly) | 3.005M |
| EPS Diluted (Quarterly) | -0.06 |
| Earnings Yield | -6.12% |